Aeterna Zentaris Stock Price - AEZS

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 1.10 ▲ 0.03 (2.80%)
Company Name Stock Ticker Symbol Market Type
Aeterna Zentaris Inc AEZS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.07 7.0% 1.07 1.19 0.999 0.999 1.00 18:01:08
Bid Price Ask Price Spread Spread % News
0.94 1.30 0.36 27.69% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,103 528,033 $ 1.10 $ 581,445 212,745 0.8125 - 5.5869
Last Trade Time Type Quantity Stock Price Currency
17:26:03 formt 350 $ 1.10 USD

Aeterna Zentaris Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 21.35M 19.95M $ 4.19M 0.25 - 19.88M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Aeterna Zentaris News

Loading Messages....

Latest AEZS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AEZS Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.91.190.83980.9167131k0.1718.89%
1 Month1.61.670.81251.0855238k-0.53-33.13%
3 Months2.372.570.81251.4862145k-1.3-54.85%
6 Months4.344.38130.81252.2591139k-3.27-75.35%
1 Year1.545.58690.81252.9470334k-0.47-30.52%
3 Years4.065.590.78162.5075533k-2.99-73.65%
5 Years1061350.781613.79762M-104.93-98.99%

Aeterna Zentaris Description

AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline.

Your Recent History
Aeterna Ze..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.